Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
267624,GNRL,"COMSORT, Inc",MD,100000000055,150.00,12/03/2013,GNRL,103042712
267624,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,115.69,06/27/2014,GNRL,158748458
267624,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,112.40,07/22/2014,GNRL,158748018
267624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,99.00,11/06/2014,GNRL,155919972
267624,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,63.66,05/23/2014,GNRL,221174790
267624,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,50.28,08/07/2015,GNRL,319340411
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,44.56,02/14/2014,GNRL,148435372
267624,GNRL,"Dexcom, Inc.",CA,100000010478,27.55,09/17/2015,GNRL,334998574
267624,GNRL,"Eisai Inc.",NJ,100000000136,20.64,11/21/2014,GNRL,184676490
267624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,19.04,08/29/2014,GNRL,193624814
267624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,18.66,09/27/2013,GNRL,23817177
267624,GNRL,"Auxilium Pharmaceuticals, Inc.",PA,100000010522,17.67,04/03/2014,GNRL,212011826
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.14,03/13/2014,GNRL,149261020
267624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.66,09/25/2013,GNRL,104426004
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.23,11/20/2014,GNRL,148171010
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.23,09/19/2014,GNRL,149548440
267624,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.08,03/27/2015,GNRL,266702810
267624,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,15.00,09/21/2015,GNRL,263310390
267624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.34,11/07/2013,GNRL,23817178
267624,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.28,04/30/2015,GNRL,290796878
267624,GNRL,"Pfizer Inc.",NY,100000000286,13.25,10/09/2014,GNRL,206458174
267624,GNRL,"Supernus Pharmaceuticals, Inc.",MD,100000011150,13.23,07/17/2014,GNRL,206962496
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.17,10/24/2014,GNRL,148938966
267624,GNRL,"Endo Pharmaceuticals Inc.",PA,100000000285,12.99,06/08/2015,GNRL,338842160
267624,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.70,06/05/2015,GNRL,266790076
267624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.59,10/16/2014,GNRL,155919970
267624,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,12.48,12/12/2014,GNRL,145867270
267624,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.42,03/06/2015,GNRL,274929652
267624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.18,11/08/2014,GNRL,193624808
267624,GNRL,"Lundbeck LLC",IL,100000000236,11.87,02/26/2015,GNRL,294011236
267624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.78,04/24/2015,GNRL,331633807
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.61,11/15/2013,GNRL,12267481
267624,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.54,02/12/2015,GNRL,336873992
267624,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.42,11/09/2013,GNRL,14045679
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.40,07/11/2014,GNRL,149609891
267624,GNRL,"Eisai Inc.",NJ,100000000136,11.25,01/09/2014,GNRL,184676486
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.15,01/30/2015,GNRL,255141016
267624,GNRL,"Noven Pharmaceuticals, Inc.",FL,100000000219,11.02,08/07/2014,GNRL,217878622
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.01,03/03/2015,GNRL,256252558
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.86,03/27/2015,GNRL,256338508
267624,GNRL,"Lundbeck LLC",IL,100000000236,10.85,05/21/2015,GNRL,294011242
267624,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.58,10/23/2014,GNRL,202275054
267624,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.56,06/26/2014,GNRL,145867258
267624,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.49,03/06/2014,GNRL,149898540
267624,GNRL,"Roche Diagnostics Corporation",IN,100000005419,10.47,04/03/2015,GNRL,300013752
267624,GNRL,"Eisai Inc.",NJ,100000000136,10.21,08/16/2013,GNRL,152466764
267624,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,10.09,08/09/2013,GNRL,12883400
267624,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,6.89,12/18/2014,GNRL,158773880
267624,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,5.30,06/27/2014,GNRL,158825164
267624,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,4.47,06/27/2014,GNRL,158703140
